agilon health, inc. (AGL): Nasdaq/NYSE listing notice — agilon health receives NYSE delisting notice; plans reverse stock split

agilon health, inc.

NYSE notified agilon on Nov 5, 2025 that avg closing price was below $1.00 over 30 trading days ended Nov 4, 2025.
Stock continues trading on NYSE during six-month cure period; no immediate impact on listing or business operations.
To regain compliance, agilon intends to seek shareholder approval for a reverse stock split at 2026 annual meeting.
Company must notify NYSE by Nov 19, 2025 of intent to remain listed and cure the deficiency.
If reverse split approved and implemented, share price must promptly exceed $1.00 and stay above for at least 30 trading days.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

agilon health, inc. received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

Exchange: nyse
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 802.01C

Exact text from the filing

November 5, 2025, agilon health, inc. (the “Company”) received written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) informing the Company that it is no longer in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company’s common stock was less than $1.00 per share over a consecutive 30 trading-day period ended November 4, 2025 (the “Price Criteria for Capital or Common Stock”). The Company can regain compliance at any time within the six-month period following receipt of the Notice if, on the last trading day of an

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

agilon health, inc. filing history →

Source: SEC EDGAR

accession 0001628280-25-050412

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.